Jazz Pharmaceuticals Public Limited Company JAZZ was a big mover last session, as the company saw its shares rise nearly 9% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $132.55 to $153.48 in the past one-month time frame, showed a pick-up yesterday at $144.23.
The company has seen 1 estimate revision over the past 30 days and its Zacks Consensus Estimate moved higher over the same time period, suggesting that more solid trading could be ahead for Jazz. So make sure to keep an eye on this stock going forward to see if yesterday's gain can turn into more strength down the road.
Jazz Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other better ranked biotechnology stocks include Endo International plc ENDP, Hyperion Therapeutics, Inc. HPTX and PharmAthene, Inc. PIP all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
JAZZ PHARMACEUT JAZZ: Free Stock Analysis Report
ENDO INTL PLC ENDP: Free Stock Analysis Report
HYPERION THERAP HPTX: Free Stock Analysis Report
PHARMATHENE INC PIP: Get Free Report
To read this article on Zacks.com click here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
